-
Mashup Score: 0Use of CGM Linked to Lower Risk of Retinopathy in Type 1 Diabetes - 10 hour(s) ago
Use of CGM devices, either solo or with insulin pumps, tied to lower odds of the complication
Source: www.medpagetoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 17Researchers use algorithm to provide innovative insights into the heterogeneity of type 2 diabetes - 11 hour(s) ago
A landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers have employed an innovative …
Source: medicalxpress.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2Eating more plant-based foods may lower diabetes risk - 5 day(s) ago
Middle-aged adults who eat more plant-based foods and fewer animal-based products are less likely to develop incident diabetes, according to study findings published in Diabetes Care. In an analysis of data from adults who participated in the Atherosclerosis Risk in Communities (ARIC) study, researchers found those who adhered closest to an eating pattern that included fruits, vegetables, whole
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 2Eating more plant-based foods may lower diabetes risk - 6 day(s) ago
Middle-aged adults who eat more plant-based foods and fewer animal-based products are less likely to develop incident diabetes, according to study findings published in Diabetes Care. In an analysis of data from adults who participated in the Atherosclerosis Risk in Communities (ARIC) study, researchers found those who adhered closest to an eating pattern that included fruits, vegetables, whole
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 14
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
The purpose of the study was to develop care and professional education competencies that address prediabetes, diabetes, and cardiometabolic conditions at the individual and population levels and to promote self-assessment and professional development goals related to the knowledge, skills, and abilities required to effectively work with PWD and related conditions. There are 130 million Americans currently living with, affected by, or at risk for diabetes. As a result, clinicians, nonclinical providers,
Source: journals.sagepub.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 21Study reveals genetic clusters and biological pathways that may explain differences in type 2 diabetes risk - 12 day(s) ago
The development and progression of type 2 diabetes are affected by numerous biological processes, such as the body’s response to insulin, the health of insulin-producing pancreatic beta cells, and the …
Source: medicalxpress.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Maternal Study Satisfaction Increases Visit Compliance in Children at Risk for Diabetes - 13 day(s) ago
Maternal characteristics, sociodemographic factors, and paternal participation during the initial year of the TEDDY study were identified as key predictors of enhanced visit compliance in a pediatric cohort genetically predisposed to type 1 diabetes.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 10FLOW: Semaglutide slows CKD progression, cuts risks for kidney, CV death in diabetes - 14 day(s) ago
Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.The FLOW trial enrolled 3,533 people with type 2 diabetes and CKD. Participants were randomly assigned to receive either once-weekly semaglutide 1 mg (Ozempic, Novo
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1
Cutting-edge advancements in endocrinology continue to move diabetes treatment in the right direction faster than ever before. The treatment of diabetes is continually evolving. More than a century ago, a diabetes diagnosis was a death sentence, and although there is not yet a cure, endless updates in diabetes care help ease the burden of both…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet
"That is a very encouraging message." -- T. Y. Alvin Liu, MD, of @HopkinsMedicine, after finding continuous glucose monitoring may reduce the risk of diabetic retinopathy in type 1 #diabetes. @MedPageEndo https://t.co/GDmkvgw2Lq